LINC02582

Across TCGA pan-cancer cohorts, LINC02582 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02582 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02582 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02582 expression acts as an unfavorable survival marker, although some lineages such as CESC and OV show a favorable association.

COAD, MESO, and ACC are the cancer types where LINC02582 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.398	0.579	<.001	149	view →
MESO	DFS	Quartile	III,IV	0.163	0.413	<.001	117	view →
ACC	DFS	Tertile	III,IV	0.033	0.381	<.001	99	view →
KICH	DFS	Tertile	All	0.218	0.889	<.001	75	view →
CESC	DFS	Median	All	0.821	0.685	.005	38	view →
UCEC	OS	Tertile	All	0.890	0.939	.009	34	view →
KIRC	DFS	Quartile	All	0.559	0.696	.006	25	view →
STAD	DFS	Quartile	All	0.524	0.756	.013	24	view →
SARC	OS	Tertile	All	0.316	0.558	<.001	24	view →
CHOL	OS	Tertile	II,III,IV	0.024	0.601	.025	18	view →
UVM	DFS	Tertile	III,IV	0.104	0.677	.001	18	view →
ESCA	OS	Tertile	All	0.443	1.000	.033	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02582–COAD (DFS)

Open the COAD breakdown →